Use of TNFR2 agonist antibody to enhance potent regulatory T cells in allergen-specific immunotherapy

Project Details

AcronymEAACI-TNFR2
StatusFinished
Effective start/end date1/10/2231/03/23

Funding

  • European Academy of Allergy and Clinical Immunology (EAACI): €12,500.00